ERIM
ARRY

Eagle Ridge Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Eagle Ridge Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,000
Closed -$50K – 61
2013
Q4 		$50K Sell
10,000
-10,000
-50% -$54.4K 0.03% 56
2013
Q3 		$124K Buy
+20,000
New +$119K 0.07% 49

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eagle Ridge Investment Management's ARRY Position: Q1 2014 in Review

Eagle Ridge Investment Management sold out of Array Biopharma Inc (ARRY) in Q1 2014, closing a stake of 10,000 shares — an estimated $50K sold.

Eagle Ridge Investment Management first reported a position in ARRY in Q3 2013 and held it in 2 quarters. The position peaked at $124K in Q3 2013. 122 funds tracked by Wall St. Rank hold ARRY as of Q1 2014.

  • Eagle Ridge Investment Management reported no remaining Array Biopharma Inc position as of Q1 2014 after selling out during the quarter.
  • Eagle Ridge Investment Management sold 10,000 Array Biopharma Inc shares in Q1 2014, an estimated $50K.
  • Eagle Ridge Investment Management first reported a position in Array Biopharma Inc in Q3 2013 and held it in 2 quarters.
  • Eagle Ridge Investment Management's Array Biopharma Inc position peaked at $124K in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2014.

Based on Eagle Ridge Investment Management's 13F filing for Q1 2014, filed 17 Apr 2014.